ArticleInternal medicine (Tokyo, Japan)2019

Bromocriptine as a Potential Glucose-lowering Agent for the Treatment of Prolactinoma with Type 2 Diabetes.

Tamami Oshige et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.